Top Markets
Coin of the day
Scilex Holding Company Scilex Holding Company

Scilex Holding Company

SCLX
Rangering i aksjer #25627
Scilex Holding Company is a biopharmaceutical enterprise that specializes in... Scilex Holding Company is a biopharmaceutical enterprise that specializes in the development and market introduction of non-opioid therapies designed to alleviate both acute and chronic pain. Its primary marketed offering is ZTlido 1.8%, a topical prescription formulation of lidocaine specifically engineered to mitigate neuropathic discomfort associated with post-herpetic neuralgia, a condition characterized by persistent nerve pain following shingles. Beyond this, the company's development pipeline includes SP-102, a viscous gel corticosteroid for epidural administration, currently undergoing Phase III trials for lumbosacral radicular pain. Another candidate, SP-103, is progressing through Phase II trials for managing low back pain. Furthermore, SP-104, a novel, low-dose, delayed-release naltrexone hydrochloride formulation, has successfully concluded Phase I clinical testing for the treatment of fibromyalgia. Its corporate offices are situated in Palo Alto, California. Scilex Holding Company operates as a subsidiary of Sorrento Therapeutics, Inc.
Aksjekurs
$5.61
Sist synkronisert: 2026-08-20
Markedsverdi
$47.65M
Endring (1 dag)
-0.68%
Endring (1 år)
-67.26%
Land
US
Handel Scilex Holding Company (SCLX)

Kategori

Aksjeprishistorikk for Scilex Holding Company (SCLX)
Høyeste sluttskurs: $6.52 den 2026-08-01

Laveste sluttskurs: $346.22 den 2021-03-01
Aksjeprishistorikk for Scilex Holding Company fra 2021 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -26.12%
2025 -11.79%
2024 -61.32%
2023 -63.10%
2022 -63.74%
2021 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$1.25K 75.69%
US
$268.08 49.82%
US
$262.00 25.06%
US
$489.01 44.10%
CH
$149.16 73.28%
US